Effectiveness of Levetiracetam in the Treatment of Lumbar Radiculopathy: An Open‐Label Prospective Cohort Study

[1]  H. von Giesen,et al.  Efficacy and safety of pregabalin in treatment refractory patients with various neuropathic pain entities in clinical routine , 2007, International journal of clinical practice.

[2]  B. Stacey,et al.  Neuropathic pain symptoms relative to overall pain rating. , 2004, The journal of pain : official journal of the American Pain Society.

[3]  M. Price.  Levetiracetam in the Treatment of Neuropathic Pain: Three Case Studies , 2004, The Clinical journal of pain.

[4]  Mario Saltarelli,et al.  Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. , 2003, Archives of neurology.

[5]  R. Dworkin.  An Overview of Neuropathic Pain: Syndromes, Symptoms, Signs, and Several Mechanisms , 2002, The Clinical journal of pain.

[6]  M. Backonja.  Use of anticonvulsants for treatment of neuropathic pain , 2002, Neurology.

[7]  H. Klitgaard.  Levetiracetam: The Preclinical Profile of a New Class of Antiepileptic Drugs? , 2001, Epilepsia.

[8]  M. Privitera.  Efficacy of Levetiracetam: A Review of Three Pivotal Clinical Trials , 2001, Epilepsia.

[9]  Cynthia L. Harden.  Safety Profile of Levetiracetam , 2001, Epilepsia.

[10]  W. Löscher,et al.  Development of Tolerance During Chronic Treatment of Kindled Rats With the Novel Antiepileptic Drug Levetiracetam , 2000, Epilepsia.

[11]  T. Dillingham,et al.  Identifying Lumbosacral Radiculopathies: An Optimal Electromyographic Screen , 2000, American journal of physical medicine & rehabilitation.

[12]  D. Margineanu,et al.  Inhibition of neuronal hypersynchrony in vitro differentiates levetiracetam from classical antiepileptic drugs. , 2000, Pharmacological research.

[13]  Simon Shorvon,et al.  Multicenter Double‐Blind, Randomized, Placebo‐Controlled Trial of Levetiracetam as Add‐On Therapy in Patients with Refractory Partial Seizures , 2000 .

[14]  M. Backonja.  Anticonvulsants (Antineuropathics) for Neuropathic Pain Syndromes , 2000, The Clinical journal of pain.

[15]  I. Leppik,et al.  Absence of Pharmacokinetic Drug Interaction of Levetiracetam with Phenytoin in Patients with Epilepsy Determined by New Technique , 2000, Journal of clinical pharmacology.

[16]  P. Patsalos.  Pharmacokinetic profile of levetiracetam: toward ideal characteristics. , 2000, Pharmacology & therapeutics.

[17]  T. Jensen,et al.  Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action , 1999, PAIN®.

[18]  Hansen Hc.  Treatment of chronic pain with antiepileptic drugs: a new era. , 1999 .

[19]  C. Woolf,et al.  Neuropathic pain: aetiology, symptoms, mechanisms, and management , 1999, The Lancet.

[20]  G. Bennett.  Neuropathic pain: new insights, new interventions. , 1998, Hospital practice.

[21]  W. Kingery,et al.  A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes , 1997, Pain.

[22]  Dawn Carroll,et al.  Anticonvulsant drugs for management of pain: a systematic review , 1995, BMJ.

[23]  P. Césaro,et al.  Pharmacology of neuropathic pain. , 1995, Clinical neuropharmacology.

[24]  C. Cleeland,et al.  Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases , 1983, Pain.

[25]  S. Sherman,et al.  Effectiveness of tizanidine in neuropathic pain: an open-label study. , 2000, The journal of pain : official journal of the American Pain Society.

[26]  S. Shorvon,et al.  Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam Study Group. , 2000, Epilepsia.

[27]  Hans C. Hansen.  Treatment of chronic pain with antiepileptic drugs: a new era. , 1999, Southern medical journal.